.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Cantor Fitzgerald
Chinese Patent Office
Colorcon
Dow
Fish and Richardson
Fuji
McKinsey
McKesson
Baxter

Generated: November 22, 2017

DrugPatentWatch Database Preview

Drug Master Files for: Leo Pharm

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
3237III6/5/1978LEO PHARMACEUTICAL PRODUCTS LTDMECILLINAM FOR INJECTION
4548III3/18/1982LEO PHARMACEUTICAL PRODUCTS LTDFACILS & CONTROLS USED IN GR OF SODIUM FUSIDATE CAPS.
4593III7/7/1982LEO PHARMACEUTICAL PRODUCTS LTDPERSONNEL, FACILITIES AND GENERAL OPERATING PROCEDURES
6884III3/23/1987LEO PHARMACEUTICAL PRODUCTS LTDSODIUM TAURO-24,25-DIHYDROFUSIDATE BULK SUBSTANCE
7649III6/30/1988PHARMACIA LEO PHARMACEUTICALSFACILITIES, PERSONNEL AND PROCEDURES IN HELSINGBORG, SWEDEN
8308III11/1/1989LEO PHARMA ASCALCIPOTRIENE DRUG SUBSTANCE
8312III11/27/1989LEO PHARMA ASCALCIPOTRIENE OINTMENT
8313III11/27/1989LEO PHARMACEUTICAL PRODUCTS LTDFACILITIES AND OPERATING PROCEDURES IN BALLERUP, DENMARK
8322III11/27/1989LEO PHARMACEUTICAL PRODUCTS LTDFACILITIES AND OPERATING PROCEDURES
8526III4/16/1990LEO PHARMACEUTICAL PRODUCTS LTDFUSIDIC ACID
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Fish and Richardson
Queensland Health
Cerilliant
AstraZeneca
McKesson
Teva
Healthtrust
Chinese Patent Office
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot